Assignment

Course Title: Working Capital Management

Course Code: FIN 406

Submitted To:
Ms. Tasnima Aziza
Assistant Professor,
IBA-JU.

Submitted By:
1. Sams Saiyadena Zeesha
Id: 1642
2. Farhan Anjum Junayed
Id: 1657

Date of Submission:13th August, 2018

Square Pharmaceuticals Ltd:
Annual Report 2016-2017
1. Cash and Cash Equivalents- BDT 15,689,575,448
2. Investment in Marketable Securities (Fair Value)- BDT 1,835,191,478

Kohinoor Chemicals Ltd:

Annual Report 2016-2017
1. Cash and Cash Equivalents- BDT 234,473,700
2. Investment in Marketable Securities- BDT 147,542,355
Reckitt Benckiser (Bangladesh) Ltd:
Annual Report 2017
1. Cash and cash equivalents- BDT 714,326,806
2. Investment in Marketable Securities- None

IBN SINA Pharmaceutical Industry Ltd:

Annual Report 2016-2017
1. Cash and Cash Equivalents- BDT 197,423,176
2. Investment in Marketable Securities- BDT 359,107,400

ACI Ltd:
Annual Report 2016-17
1. Cash and cash equivalents- BDT 699,121,707
2. Investment in Marketable Securities- None